Topic of the Month on ModernWeight: Diet and Exercise!
Head to the Social Hub to discuss diet and exercise routines when taking GLP-1 medications.
AOMs in the News
GLP-1 Drugs and Rising Demand Leading to Diabetes Drug Shortages
The rising demand for GLP-1 drugs, driven by their popularity in weight loss management, has led to significant shortages affecting diabetic patients. With around 9% of the adult U.S. population, approximately 22.7 million people, using GLP-1 medications, only a minority of these users have type 2 diabetes. The rapid increase in GLP-1 users has caused worldwide shortages, particularly impacting those with type 2 diabetes who rely on these medications for glucose control. A new study reports that among 1 million new GLP-1 users identified between 2011 and 2023, there was a twofold increase in users without type 2 diabetes. Additionally, the proportion of users without FDA-approved indications rose from 0.21% in 2019 to 0.37% in 2023.
Why it matters: The shortage of GLP-1 drugs highlights the need for balanced supply and demand management. For patients relying on these medications for diabetes management, the scarcity poses significant health risks. It's crucial to explore alternative solutions and ensure that those in need have access to their medications without interruption.
Public Perception of GLP-1 Drugs on Social Media
Link: Nature Article
A recent study used large language models to analyze over 390,000 Reddit discussions about GLP-1 receptor agonists. The analysis revealed 168 topics and 33 groups focused on weight loss experiences, side effects, access issues, and the psychological benefits of GLP-1 drugs. Public sentiment was mostly neutral-to-positive, highlighting the high interest and positive perception of these medications.
Why it matters: Understanding public perception can guide healthcare providers and policymakers in addressing concerns, improving patient education, and enhancing access to GLP-1 drugs. Monitoring social media discussions can also help identify new side effects and emerging trends in medication use.
High Protein Sales Boosted by GLP-1 Drugs, Especially Among Millennials
Link: Quartz Article
The surge in popularity of GLP-1 drugs has led to an unexpected increase in high-protein product sales, driven particularly by millennials. Patients on these medications are encouraged to consume more protein to support their weight loss and muscle maintenance goals, driving a significant market shift. Companies are adapting to this trend, offering more high-protein products to meet consumer demand.
Why it matters: The increased demand for high-protein products underscores the importance of dietary adjustments when using GLP-1 drugs. For those on these medications, understanding the role of protein in their diet is crucial for optimizing results and maintaining overall health. Companies adapting to this trend highlight the broader economic and social impacts of GLP-1 drug popularity.
Weight Loss Drugs: Viking Therapeutics and Roche Enter the GLP-1 Market
Link: Axios Article
Viking Therapeutics and Roche are the latest entrants in the GLP-1 drug market, developing new weight loss medications that could rival current offerings like Ozempic, Wegovy, and Zepbound. Viking Therapeutics is accelerating the development of its injectable GLP-1 treatment, VK2735, after positive feedback from the FDA. Roche is also developing a daily pill that showed promising weight loss results in early trials.
Why it matters: The entry of new players into the GLP-1 drug market can lead to more options and potentially better pricing for patients. Increased competition may drive innovation, resulting in more effective and accessible treatments for obesity and diabetes.
Weight-Loss Power of Oats Naturally Mimics Popular Obesity Drugs
Link: New Atlas Article
Oats, along with barley, contain a type of fiber that can trigger beneficial gut bacteria functions similar to those activated by GLP-1 drugs. This natural approach offers a cost-effective and side-effect-free alternative to pharmaceutical options. Scientists have identified the potential of beta-glucan, a fiber found in these grains, to naturally stimulate GLP-1 production, aiding in weight loss and glucose control.
Why it matters: Combining dietary strategies with GLP-1 medications can optimize weight loss outcomes. For patients looking to maximize the benefits of their treatment, integrating foods like oats and barley into their diet could provide significant advantages without the price tag or side effects of drugs.
Expert Tweet of the Week
From @MichaelAlbertMD
"A helpful discussion on the legal validity of compounded copycat drugs. The article explores under what circumstances compounds are valid and when they would no longer be allowed."
Read the related article here
---
Our ModernWeight "Weekly Weight Management Insights" newsletter is designed to keep you informed and engaged with the latest in weight management and GLP-1 medications. Visit the Social Hub to join the conversation and connect with our community.
Want to receive this newsletter in your inbox weekly? Create a profile!
Comments